Policy | May 09, 2026
NIPER, Raebareli signs technology transfer pact with Lofty Laboratories
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing
The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Subscribe To Our Newsletter & Stay Updated
